烏龍製藥 URGN 深 滬
已收盤 09-20 16:00:00 美东时间
13.54
-0.310
-2.24%
華盛通- 最 高14.00
- 今 開13.85
- 成交量 122.44万股
- 最 低 13.34
- 昨 收 13.85
- 總市值 4.17亿
- 52周最高 20.70
- 市盈率 靜 --
- 換手率 3.97%
- 52周最低 10.6001
- 委 比 -19.83%
- 總股本 3080.70万
- 歷史最高 69.568
- 量 比 1.62
- 振 幅 4.77%
- 歷史最低 4.85
- 每 手 1
- 風險率 1.89%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Oppenheimer’s top 32 ideas for August-September
Oppenheimer analysts updated their top equity ideas for the current month, adding (FRPT), (SLNO), and removing (WMT), and (EW), among others. These stocks are “the most timely” according to Oppenheime...
08-21 02:41
Assessing Urogen Pharma’s Market Prospects: A Hold Rating Amidst Jelmyto’s Static Sales and UGN-102’s Regulatory Journey
Urogen Pharma (URGN – Research Report), the Healthcare sector company, was revi...
08-14 04:26
UroGen Pharma Q2 2024 GAAP EPS $(0.91) Misses $(0.86) Estimate, Sales $21.848 Miss $23.963M Estimate
UroGen Pharma Q2 2024 GAAP EPS $(0.91) Misses $(0.86) Estimate, Sales $21.848 M...
08-13 20:03
UroGen Pharma Shareholders Shape Governance and Incentives
Urogen Pharma (URGN) has provided an announcement. UroGen Pharma Ltd.’s shareho...
08-09 04:59
新浪财经ESG：URGN 路孚特（Refinitiv）ESG评级调降至C+
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
07-22 07:01
UroGen Pharma stock slumps after pricing stock and warrants offering
UroGen Pharma (NASDAQ:URGN) said Tuesday it has priced an underwritten public offering of shares and warrants to raise about $107.5 million. The company plans to offer 5 million ordinary shares at $17...
06-18 21:00
UroGen Pharma commences public offering of ordinary shares
UroGen Pharma (NASDAQ:URGN) on Monday announced that it commenced an underwritten public offering to issue and sell its ordinary shares and pre-funded warrants. There can be no assurance as to whether...
06-18 05:10
快讯 | 乌龙制药：Oppenheimer将目标价从32美元上调至40美元。
Urogen Pharma Ltd : Oppenheimer Raises Target Price to $40 From $32
06-14 20:23
美股牛股 | 游戏驿站又飙14%，“带头大哥”的GME增至900万股；超微电脑大涨12%
游戏驿站又飙14%！股东大会推迟举办+“带头大哥”的GME增至900万股，看涨期权已“消失”；乌龙制药飙升37.6%，高盛上调目标价至22美元>>
06-14 18:56
快讯 | 乌龙制药：H.c. Wainwright将目标价从54美元上调至60美元。
Urogen Pharma Ltd : H.c. Wainwright Raises Target Price to $60 From $54
06-14 18:07
